CDK-associated Cullin 1 promotes cell proliferation with activation of ERK1/2 in human lung cancer A549 cells.

Lung cancer is one of the most common causes of cancer-related death in the world, but the mechanisms remain unknown. In this study, we investigated the expression of CDK-associated Cullin 1 (CAC1) in lung cancer, the effect of CAC1 on the proliferation of human lung cancer A549 cells, and the activation of signaling pathways of mitogen-activated protein kinases (MAPKs). Results showed that CAC1 expression was higher levels in human lung carcinoma than normal lung tissue, and CAC1 siRNA reduced the proliferation of lung cancer A549 cells by decreasing cell activity and cell division in vitro. The proportion of cells treated with CAC1 siRNA increased in the G1 phase and decreased in the S and G2/M phase, indicative of G1 cell cycle arrest. Furthermore, the proportions of early/late apoptosis in lung cancer A549 cells were enhanced with CAC1 siRNA treatment. It was also found that activation of extracellular signal-regulated protein kinase (ERK) and p38 signaling pathways were involved in the proliferation of A549 cells. After CAC1 siRNA treatment, p-ERK1/2 levels decreased, and meanwhile p-p38 level increased, A549 cell proliferation increased when ERK1/2 signaling is activated by PMA. Our findings demonstrated that CAC1 promoted the proliferation of human lung cancer A549 cells with activation of ERK1/2 signaling pathways, suggesting a potential cure target for treatment of human lung cancer.

[1]  Y. Ho,et al.  Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERK1/2 and Chk1 kinase activation. , 2007, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  Shin-Da Lee,et al.  Estrogen-dependent facilitation on spinal reflex potentiation involves the Cdk5/ERK1/2/NR2B cascade in anesthetized rats. , 2009, American journal of physiology. Endocrinology and metabolism.

[3]  K. Nan,et al.  CDK-associated Cullin 1 can promote cell proliferation and inhibit cisplatin-induced apoptosis in the AGS gastric cancer cell line , 2013, World Journal of Surgical Oncology.

[4]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[5]  Chieh-Hsi Wu,et al.  Hispolon from Phellinus linteus has antiproliferative effects via MDM2-recruited ERK1/2 activity in breast and bladder cancer cells. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[6]  Y. Chun,et al.  Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells. , 2008, Cancer letters.

[7]  C. Sherr,et al.  D-type cyclins. , 1995, Trends in biochemical sciences.

[8]  J. Girault,et al.  Role of the ERK pathway in psychostimulant-induced locomotor sensitization , 2006, BMC Neuroscience.

[9]  K. Nan,et al.  The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer. , 2012, The international journal of biochemistry & cell biology.

[10]  Walter Kolch,et al.  Cell fate decisions are specified by the dynamic ERK interactome , 2009, Nature Cell Biology.

[11]  C. Sherr.  G1 phase progression: Cycling on cue , 1994, Cell.

[12]  S. Takasawa,et al.  Reg protein is overexpressed in gastric cancer cells, where it activates a signal transduction pathway that converges on ERK1/2 to stimulate growth , 2002, FEBS letters.

[13]  Norbert Weissmann,et al.  Targeting cancer with phosphodiesterase inhibitors , 2010, Expert opinion on investigational drugs.

[14]  E. Rudolf,et al.  The role of p38 in irinotecan-induced DNA damage and apoptosis of colon cancer cells. , 2013, Mutation research.

[15]  H. Ichijo,et al.  Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1. , 2001, Journal of biochemistry.

[16]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[17]  C. Der,et al.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer , 2007, Oncogene.

[18]  Jennifer Lee,et al.  Cullins and cancer. , 2010, Genes & cancer.

[19]  N. Zhelev,et al.  Effects of the CDK-inhibitor CYC202 on p38 MAPK, ERK1/2 and c-Myc activities in papillomavirus type 16 E6- and E7-transformed human keratinocytes. , 2007, Oncology reports.

[20]  Y. Jang,et al.  Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells. , 2012, Biochemical and biophysical research communications.

[21]  X. Chen,et al.  Involvement of ERK1/2 signaling in proliferation of eight liver cell types during hepatic regeneration in rats. , 2013, Genetics and molecular research : GMR.

[22]  Jukka Westermarck,et al.  Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  M. Mattson,et al.  p38 MAP Kinase Mediates Nitric Oxide-induced Apoptosis of Neural Progenitor Cells* , 2001, The Journal of Biological Chemistry.

[24]  A. Levy,et al.  [Molecular targeted therapies in small-cell lung cancer]. , 2010, Bulletin du cancer.

[25]  Yan Zhou,et al.  Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer. , 2011, Human pathology.

[26]  The decreased self-renewal potential of NPCs during human embryonic brain development with reduced activity of MAPKs. , 2012, Cellular and molecular biology.

[27]  A. Panani.  Cytogenetic and molecular aspects of gastric cancer: clinical implications. , 2008, Cancer letters.

[28]  Long Yu,et al.  Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal. , 2007, Biochemical and biophysical research communications.

[29]  Yuxin Yin,et al.  Identification and characterization of CAC1 as a novel CDK2-associated cullin , 2009, Cell cycle.

[30]  J. Blenis,et al.  Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[31]  M. Weyant,et al.  Secretory phospholipase A2 mediates human esophageal adenocarcinoma cell growth and proliferation via ERK 1/2 pathway. , 2013, Anticancer research.

[32]  Richard Treisman,et al.  Transcriptional Regulation by Extracellular signals: Mechanisms and Specificity , 1995, Cell.